Blair Jackson
Finanzdirektor/CFO bei ALKERMES PLC
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Blair Jackson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALKERMES PLC | Finanzdirektor/CFO | 01.02.2024 | - |
Geschäftsführer | 11.01.2021 | 01.02.2024 | |
Corporate Officer/Principal | 01.05.2016 | 11.01.2021 | |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Direktor/Vorstandsmitglied | - | - |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Direktor/Vorstandsmitglied | 01.10.2018 | - |
Karriereverlauf von Blair Jackson
Ehemalige bekannte Positionen von Blair Jackson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Direktor/Vorstandsmitglied | 11.01.2011 | 01.01.2015 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 11.08.2009 | - |
Ausbildung von Blair Jackson
University of Calgary | Undergraduate Degree |
University of Alberta | Masters Business Admin |
Massachusetts Institute of Technology | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Irland | 3 |
Kanada | 3 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALKERMES PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
- Börse
- Insiders
- Blair Jackson
- Erfahrung